Stoke Therapeutics: A Pivotal Moment For This RNA Pioneer
Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...
HotCopper.com on MSN19d
PYC Therapeutics jumps just shy of +4% as second-stage blindness drug study greenlit
PYC Therapeutics (ASX:PYC) has jumped on Friday as it moves on the the next stage of its escalating single-dose study using its drug PYC-001 to treat a genetic children’s disease causing blindness.
Business News8d
PYC’s kidney drug set for human trials
Nedlands-based biotech company PYC Therapeutics has received approvals to start human trials over a drug candidate for kidney ...
ophthalmologytimes9d
Glaucoma from the perspective of a veterinary ophthalmologist with Sara M. Thomasy, DVM, PhD, DACVO
Ophthalmology Times spoke with Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis about how her ...